Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord MSCs for Moderate/Severe cGVHD
NCT05152160Phase 2Unknown
- Sponsor
- Shenzhen University General Hospital
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in chronic graft-versus-host disease (cGVHD), sponsored by Shenzhen University General Hospital. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT05152160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05152160.